Levothyroxine formulations
DC CAFC
First Claim
Patent Images
1. A lyophilized solid composition, comprising:
- between 100 and 500 micrograms of a salt of levothyroxine;
a buffer; and
between 2 and 4 milligrams of mannitol.
2 Assignments
Litigations
1 Petition
Accused Products
Abstract
A levothyroxine composition includes levothyroxine sodium and mannitol. The composition is a lyophilized solid. The composition may include from 100 to 500 micrograms levothyroxine sodium and from 2 to 4 milligrams mannitol.
9 Citations
15 Claims
-
1. A lyophilized solid composition, comprising:
-
between 100 and 500 micrograms of a salt of levothyroxine; a buffer; and between 2 and 4 milligrams of mannitol. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15)
-
Specification
-
- Resources
Litigation Campaign Assessment
Thank you for your request. You will receive a custom alert email when the Litigation Campaign Assessment is available.
×
Litigation Data
-
Current AssigneeFresenius KABI USA LLC (Fresenius SE & Co. KGaA)
-
Original AssigneeFresenius KABI USA LLC (Fresenius SE & Co. KGaA)
-
InventorsUsayapant, Arunya, Monen, George, Jiang, John Zhiqiang
-
Primary Examiner(s)MCMILLIAN, KARA RENITA
-
Application NumberUS14/658,058Publication NumberTime in Patent Office228 DaysField of SearchUS Class Current1/1CPC Class CodesA61K 31/197 the amino and the carboxyl ...A61K 31/198 Alpha-amino acids, e.g. ala...A61K 47/02 Inorganic compoundsA61K 47/10 Alcohols; Phenols; Salts th...A61K 47/26 Carbohydrates, e.g. sugar a...A61K 9/0019 Injectable compositions; In...A61K 9/19 lyophilised , i.e. freeze-d...
